Amplify Capital portfolio company Invivo.ai has joined Mila’s efforts to develop novel data-driven solutions to assist with COVID-19 outbreak.
“Sébastien Giguère from InVivo AI leads a data-efficient deep learning to better model emerging biology. The COVID-19 outbreak offers a solemn reminder of how little we know about emerging biology. Novel algorithms are needed for these types of data poor environments.
Launched in 2018, InVivo AI is developing novel algorithms capable of learning from small and noisy datasets. In light of the COVID-19 outbreak, the startup is leveraging their platform to learn models of pathways in the immune system to better predict immune response. The team is working on modeling proteasomal cleavage, TAP transport, antigen binding to MHC, antigen processing to the cell surface and recognition of MHC-antigen complexes by T-Cells and B-cells, with the goal of providing insight into immunogenic regions of the virus.”